BRCA1 and breast cancer: Several preclinical studies have suggested that BRCA1-related BC cell lines show a varying degree of sensitivity to different chemotherapeutic agents [16,17,18,19], explaining the distinct pathologic features in hereditary BC compared with sporadic cancer [20,21].